Paul C. Parkinson's Insider Trades & SAST Disclosures
Paul C. Parkinson's most recent trade in Myriad Genetics, Inc. was a trade of 10,661 Common Stock done . Disclosure was reported to the exchange on March 24, 2021.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Paul C. Parkinson.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Myriad Genetics, Inc. | Paul Chip Parkinson | EVP Strategy and Innovation | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2021 | 10,661 | 87,407 (0%) | 0% | 0 | Common Stock | |
| Myriad Genetics, Inc. | Paul Chip Parkinson | EVP Strategy and Innovation | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 08 Jan 2021 | 11,824 | 76,746 (0%) | 0% | 25 | 295,600 | Common Stock |
| Myriad Genetics, Inc. | Paul C. Parkinson | EVP Strategy and Innovation | Sale or transfer of securities back to the company at price $ 12.43 per share. | 31 Oct 2020 | 2,218 | 88,570 (0%) | 0% | 12.4 | 27,570 | Common Stock |
| Myriad Genetics, Inc. | Paul C. Parkinson | EVP Strategy and Innovation | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2020 | 21,730 | 90,788 (0%) | 0% | 0 | Common Stock | |
| Myriad Genetics, Inc. | Paul C. Parkinson | EVP Strategy and Innovation | Sale or transfer of securities back to the company at price $ 12.44 per share. | 25 Sep 2020 | 3,327 | 69,058 (0%) | 0% | 12.4 | 41,388 | Common Stock |
| Myriad Genetics, Inc. | Paul C. Parkinson | EVP Strategy and Innovation | Sale or transfer of securities back to the company at price $ 12.44 per share. | 25 Sep 2020 | 2,218 | 72,385 (0%) | 0% | 12.4 | 27,592 | Common Stock |
| Myriad Genetics, Inc. | Paul C. Parkinson | EVP Strategy and Innovation | Sale or transfer of securities back to the company at price $ 12.44 per share. | 25 Sep 2020 | 2,218 | 74,603 (0%) | 0% | 12.4 | 27,592 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges